ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ESTEVE-EBITDA-ESG

More Like This

PR Newswire associated0

ESTEVE INCREASES NET REVENUE BY 5% AND REAFFIRMS STRATEGY TOWARDS BECOMING A HIGHLY SPECIALIZED COMPANY

PR Newswire associated0

ESTEVE Acquires Regis Technologies, expanding U.S. presence and capabilities

PR Newswire associated0

ESTEVE to acquire TerSera Therapeutics' Infusion Specialty Therapies Business Unit, Expanding U.S. presence

Almirall HQ in Barcelona (Photo: Business Wire)

Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth

Business Wire logo

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

PR Newswire associated0

/C O R R E C T I O N -- Suanfarma/

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

PR Newswire associated0

ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment